The Coming Consequences of Banking Fraud [View article]
While there may be a grain (or two) of truth in this article, it is so full of opinion and color that it loses just about all credibility. So many words, so little substance.
I'm a lot less conspiratorial, a little more analytical (& balanced), and maybe a little more optimistic (tho not by much) than Mr. Kim.
Most interesting insight: 1/3 of the 15 "most successful" stocks were acquired during the year, and Rohm & Haas may still be.
At least one, H&R Block, was coming off a spectularly calamitous 2007--and had nowhere to go (other than bankruptcy) than up.
On the down side, financials and real estate accounted for most of the big losers--and I mean really BIG!
Several value consumer plays in the list, led by Wal-Mart as well as a few bio-techs, led by Amgen. I expect that, if money can be made in the market this year, the trend will be similar: buyouts, consumer staples, and healthcare bio-techs will outperform; stay away from financials and real estate.
The Coming Consequences of Banking Fraud [View article]
I'm a lot less conspiratorial, a little more analytical (& balanced), and maybe a little more optimistic (tho not by much) than Mr. Kim.
S&P's Best and Worst of 2008 [View article]
At least one, H&R Block, was coming off a spectularly calamitous 2007--and had nowhere to go (other than bankruptcy) than up.
On the down side, financials and real estate accounted for most of the big losers--and I mean really BIG!
Several value consumer plays in the list, led by Wal-Mart as well as a few bio-techs, led by Amgen. I expect that, if money can be made in the market this year, the trend will be similar: buyouts, consumer staples, and healthcare bio-techs will outperform; stay away from financials and real estate.